IDEAYA Biosciences (IDYA) Misses Q1 EPS by 12c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q1 EPS of ($1.11), $0.12 worse than the analyst estimate of ($0.99). Revenue for the quarter came in at $6.56 million versus the consensus estimate of $5.19 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• FDA launches Operation TrialBlazer to accelerate drug research
• Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters